Third Harmonic Bio
Stock Forecast, Prediction & Price Target
Third Harmonic Bio Financial Estimates
Third Harmonic Bio Revenue Estimates
Third Harmonic Bio EBITDA Estimates
Third Harmonic Bio Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
Net Income
% change YoY
| $-29.60M N/A | $-37.70M -27.35% | $-30.82M 18.25% | Avg: $-65.75M Low: $-75.32M High: $-43.21M avg. -113.31% | Avg: $-82.16M Low: $-91.18M High: $-57.88M avg. -24.96% | Avg: $-80.48M Low: $-80.48M High: $-80.48M avg. 2.05% | Avg: $-81.47M Low: $-81.47M High: $-81.47M avg. -1.23% |
EBITDA
% change YoY
| $-19.00M N/A | $-37.70M -98.42% | $-30.78M 18.34% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$0.77 N/A | -$0.96 -24.67% | -$0.78 18.74% | Avg: -$1.41 Low: -$1.9 High: -$1.09 avg. -81.08% | Avg: -$1.76 Low: -$2.3 High: -$1.46 avg. -24.36% | Avg: -$2.03 Low: -$2.03 High: -$2.03 avg. -15.55% | Avg: -$2.06 Low: -$2.06 High: -$2.06 avg. -1.23% |
Operating Expenses
% change YoY
| $19.00M N/A | $37.70M 98.42% | $43.95M 16.56% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Third Harmonic Bio stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -34.36% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -75.32M, average is -65.75M and high is -43.21M.
What is Third Harmonic Bio stock revenue growth forecast?
We have gathered data from 4 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Third Harmonic Bio stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -30.56% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$1.9, average is -$1.41 and high is $-1.09.
What is the best performing analyst?
In the last twelve months analysts have been covering Third Harmonic Bio stock. The most successful analyst is Alex Thompson.